跳至主要内容
临床试验/NCT00901095
NCT00901095已完成2 期

Can Diet- & Exercise-induced Weight Loss Improve Asthma Control in Adults

Palo Alto Medical Foundation8 个研究点 分布在 1 个国家目标入组 330 人开始时间: 2010年2月1日最近更新:
适应症
干预措施

试验速览

阶段
2 期
状态
已完成
入组人数
330
试验地点
8
主要终点
Asthma Control Questionnaire

研究概览

简要总结

The goal of the study is to investigate the efficacy of an evidence-based weight loss intervention, on a background of quality health care, on asthma control among obese adults. The intervention will employ a combination of recommended dietary and physical activity changes, and behavioral modification techniques.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
Single (Investigator)

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Participants will meet all of the following:
  • •Age: 18-70 years of age;
  • •Obesity: BMI >30.0 kg/m2;
  • •Physician-diagnosed asthma that is poorly controlled:
  • •Documented diagnosis of asthma on the current medical problem list
  • •Currently prescribed an anti-asthma medication
  • •Overall score <20 on the Asthma Control Test (ACT)64 or a score<3 on any of the first four ACT questions regarding symptoms, nighttime awakening, interference with normal activity, and SABA use for symptom relief
  • •Demonstrable airway reversibility
  • •Seen in primary care at Kaiser at least once in the preceding 24 months;
  • •KPNC member for >1 year.

排除标准

  • •Any of the following will exclude participants from the study:
  • •Inability to speak, read or understand English;
  • •Intermittent asthma, defined as either seasonal asthma or (daytime asthma symptoms < 2x/week and nocturnal symptoms < 2x/month and no use of long-term control medications);
  • •Diagnosis of COPD (emphysema or chronic bronchitis) on the current medical problem list or suggested by spirometry at baseline;
  • •Unwilling to attempt weight loss, including unwillingness to perform self-monitoring;
  • •Body weight change (+/-) > 10 pounds or use of weight-loss medications in the preceding 3 months;
  • •Inability to perform pulmonary function tests by spirometry in a consistent manner;
  • •Significant medical co-morbidities, including uncontrolled metabolic disorders (e.g., thyroid, diabetes, renal, liver), unstable heart disease, heart failure, and ongoing substance abuse;
  • •Diagnosis of psychiatric disorders that would limit adequate informed consent or ability to comply with study protocol;
  • •Regular use of medications that can cause weight gain (e.g., oral corticosteroids, insulin, certain oral hypoglycemics, certain antidepressants, etc.);
  • •Under treatment for cancer or another condition that may prevent completion of follow-up;
  • •Diagnosis of a terminal illness and/or in hospice care;
  • •Use of a pacemaker or other implanted medical devices;
  • •Pregnant, planning to become pregnant, or lactating;
  • •Actively enrolled in a care management program focused on weight loss at Kaiser or elsewhere;
  • •Already enrolled or planning to enroll in a research study that would limit full participation in the study or confound the observation and interpretation of the study's findings;
  • •Family household member already enrolled in the study;
  • •No longer receiving primary care from Kaiser, or planning not to do so within the study period;
  • •PCP determination that the study is inappropriate or unsafe for the patient;
  • •Investigator discretion for clinical safety or protocol adherence reasons.

研究组 & 干预措施

Control

No Intervention

Usual Care

Lifestyle intervention

Experimental

The Lifestyle intervention group consists of in-person meetings co-led by an exercise specialist and dietician as well as follow-ups with an interventionist by phone.

干预措施: Lifestyle intervention (Behavioral)

结局指标

主要结局

Asthma Control Questionnaire

时间窗: Baseline, 6- and 12-months

次要结局

  • Patient Satisfaction(Baseline and 12-month)
  • BMI, diet, and physical activity(Baseline, 6- and 12-months)
  • Adverse Events(6- and 12-months)
  • Lung function(Baseline, 6-, and 12-months)
  • Quality of Life(Baseline, 6- and 12-months)
  • Symptom-free days(Baseline, 6- and 12-month)
  • Asthma-related and total health care utilization(Baseline, 6- and 12-month)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jun Ma, MD, PhD

Associate Investigator

Palo Alto Medical Foundation

研究点 (8)

Loading locations...

相似试验